Market Closed -
Bombay S.E.
06:00:48 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
2,204
INR
|
-0.74%
|
|
+0.60%
|
-17.41%
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
57,118
|
94,033
|
62,944
|
71,410
|
-
|
-
|
Enterprise Value (EV)
1 |
57,118
|
94,033
|
62,944
|
71,410
|
71,410
|
71,410
|
P/E ratio
|
24
x
|
25.5
x
|
19.3
x
|
35.5
x
|
24.3
x
|
18
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
4.05
x
|
2.67
x
|
4.34
x
|
3.43
x
|
3.02
x
|
EV / Revenue
|
-
|
4.05
x
|
2.67
x
|
4.34
x
|
3.43
x
|
3.02
x
|
EV / EBITDA
|
-
|
14.9
x
|
10.3
x
|
21.8
x
|
15.1
x
|
12.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
7.52
x
|
-
|
4.28
x
|
3.71
x
|
-
|
Nbr of stocks (in thousands)
|
32,401
|
32,401
|
32,401
|
32,401
|
-
|
-
|
Reference price
2 |
1,763
|
2,902
|
1,943
|
2,220
|
2,220
|
2,220
|
Announcement Date
|
5/24/21
|
5/12/22
|
5/21/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
23,204
|
23,554
|
16,443
|
20,802
|
23,626
|
EBITDA
1 |
-
|
6,302
|
6,091
|
3,278
|
4,740
|
5,788
|
EBIT
1 |
-
|
5,881
|
5,635
|
2,715
|
3,859
|
5,081
|
Operating Margin
|
-
|
25.35%
|
23.93%
|
16.51%
|
18.55%
|
21.51%
|
Earnings before Tax (EBT)
1 |
-
|
5,783
|
5,668
|
2,953
|
4,262
|
5,424
|
Net income
1 |
2,382
|
3,684
|
3,255
|
2,024
|
2,964
|
3,987
|
Net margin
|
-
|
15.88%
|
13.82%
|
12.31%
|
14.25%
|
16.88%
|
EPS
2 |
73.52
|
113.7
|
100.5
|
62.48
|
91.51
|
123.1
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/24/21
|
5/12/22
|
5/21/23
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
5,257
|
5,649
|
7,790
|
6,702
|
6,276
|
5,859
|
4,714
|
4,637
|
4,267
|
4,688
|
3,960
|
EBITDA
1 |
-
|
1,313
|
1,587
|
1,971
|
2,147
|
1,731
|
1,278
|
931.3
|
980.4
|
683
|
736
|
883
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
903.8
|
797.5
|
895.6
|
1,087
|
1,230
|
925.7
|
625.7
|
474.1
|
527.3
|
-
|
-
|
775
|
Net margin
|
-
|
15.17%
|
15.85%
|
13.96%
|
18.35%
|
14.75%
|
10.68%
|
10.06%
|
11.37%
|
-
|
-
|
19.57%
|
EPS
|
27.90
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/2/21
|
10/27/21
|
2/2/22
|
5/12/22
|
8/12/22
|
10/27/22
|
2/6/23
|
5/21/23
|
8/31/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
34.4%
|
23.2%
|
11.6%
|
14.9%
|
15.2%
|
ROA (Net income/ Total Assets)
|
-
|
23.1%
|
17.6%
|
10.1%
|
12.5%
|
13.9%
|
Assets
1 |
-
|
15,926
|
18,540
|
20,040
|
23,715
|
28,683
|
Book Value Per Share
2 |
-
|
386.0
|
-
|
519.0
|
598.0
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/24/21
|
5/12/22
|
5/21/23
|
-
|
-
|
-
|
Last Close Price
2,220
INR Average target price
2,742
INR Spread / Average Target +23.50% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.41% | 863M | | +11.43% | 63.22B | | -3.00% | 46.34B | | +13.55% | 39.97B | | +17.83% | 25.46B | | +7.56% | 18.68B | | +0.49% | 17.24B | | -21.73% | 15.81B | | +0.56% | 14.9B | | -14.26% | 13.74B |
Other Specialty Chemicals
|